GPC3 and hepatocellular carcinoma: GPC3, a 580-AA heparin sulfate proteoglycan, is a key biomarker for early diagnosis of HCC due to its overexpression in 75% of HCC samples, but not in healthy liver or other normal tissues (Dargel et al., 2015; Zhang Q. et al., 2018).